LNK01001 not checked

Lynk Pharmaceuticals Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
6 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Ankylosing Spondylitis
Main trialPhase 3
“The aim of this study is to evaluate the efficacy and safety of LNK01001 in subjects with active ankylosing spondylitis. The study is comprised of a 16-week randomized, double-blind, parallel-group, placebo-controlled period (the Double-Blind Period); a 36-week open-label, long-term extension period (the Open-Label Extension Period). In the Double-Blind Period, participants will be randomized in a 1:1 ratio to receive either LNK01001 or placebo twice daily (BID). Participants in the placebo group will be switched to LNK01001 BID at Week 16 in the Open-Label Extension Period.”In the company’s words, NCT07237568 on ClinicalTrials.gov

Other drugs for Ankylosing Spondylitis

All 9 drugs for Ankylosing Spondylitis

Coming up1

Changes1

Last 90 days

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Nov 2026 A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Phase 3Completed 18 Apr 2025 A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
Phase 3Completed 22 Aug 2025 A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
Phase 2Completed 6 Dec 2022 A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
Phase 2Completed 29 Dec 2022 A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Phase 2Completed 14 Jun 2023 A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow LNK01001

Following is part of Solo: you see every change to LNK01001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in